Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19. Reply
| Errataetall: |
CommentOn: N Engl J Med. 2021 Dec 23;385(26):2413-2420. - PMID 34879190 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:389 |
|---|---|
| Enthalten in: |
The New England journal of medicine - 389(2023), 3 vom: 20. Juli, Seite 285-286 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Arbel, Ronen [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 21.07.2023 Date Revised 21.07.2023 published: Print CommentOn: N Engl J Med. 2021 Dec 23;385(26):2413-2420. - PMID 34879190 Citation Status MEDLINE |
|---|
| doi: |
10.1056/NEJMc2306683 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM35970803X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35970803X | ||
| 003 | DE-627 | ||
| 005 | 20231226081441.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1056/NEJMc2306683 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1198.xml |
| 035 | |a (DE-627)NLM35970803X | ||
| 035 | |a (NLM)37470347 | ||
| 035 | |a (PII)10.1056/NEJMc2306683#sa2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Arbel, Ronen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19. Reply |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.07.2023 | ||
| 500 | |a Date Revised 21.07.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: N Engl J Med. 2021 Dec 23;385(26):2413-2420. - PMID 34879190 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a BNT162 Vaccine |2 NLM | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Sergienko, Ruslan |e verfasserin |4 aut | |
| 700 | 1 | |a Netzer, Doron |e verfasserin |4 aut | |
| 700 | 1 | |a Hammerman, Ariel |e verfasserin |4 aut | |
| 700 | 1 | |a Friger, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Peretz, Alon |e verfasserin |4 aut | |
| 700 | 1 | |a Razi, Talish |e verfasserin |4 aut | |
| 700 | 1 | |a Duskin-Bitan, Hadar |e verfasserin |4 aut | |
| 700 | 1 | |a Yaron, Shlomit |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d 1945 |g 389(2023), 3 vom: 20. Juli, Seite 285-286 |w (DE-627)NLM000008184 |x 1533-4406 |7 nnns |
| 773 | 1 | 8 | |g volume:389 |g year:2023 |g number:3 |g day:20 |g month:07 |g pages:285-286 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1056/NEJMc2306683 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 389 |j 2023 |e 3 |b 20 |c 07 |h 285-286 | ||